Canadian clinician scientists are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Blood Cancer Quality of Life Grant Competition offered in partnership with The Canadian Cancer Society.
According to the latest statistics, approximately 150,000 Canadians are living with or are in remission from a blood cancer. The 5-year survival rates vary depending on the blood cancer and can range from 25% to 90%.
Quality of life issues for blood cancer patients have been less well studied than other phases of care. There are many medical and non-medical consequences of treatments that vary with age, sex, gender, ethnicity, type of blood cancer, and treatment. Some cancer survivors experience few adverse effects once the active treatment phase is over, whereas others may experience a wide range of physiological, psychological and psychosocial effects that may continue for many years.
The intent of this funding opportunity is to support new research designed to address quality of life challenges experienced by Canadians affected by blood cancers. Quality of life cancer research has the potential to make a significant impact on the burden of disease in patients, survivors and caregivers.
Key dates for 2021-2022
- Call for Proposals: Nov 1, 2021
- Letter of Intent (LOI) due: Dec 1, 2021, 4:00 pm
- Notification of Full Application Invite: Dec 2021
- Full application deadline: Jan 21, 2022, 4:00 pm EST
- Review Panel Meeting: April 2022
- Notification of Awards: May 2022
- Award Start Date: July 2022
Read the guidelines
Applicants must carefully read the program guidelines before beginning their applications.
- Download – LLSC Blood Cancer Quality of Life Grant Competition Guidelines & Instructions
- Download – LLSC Blood Cancer Quality of Life Grant Policies and Procedures